Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Po Sing Leung

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8074-3178; OpenAlex author ID A5024549935. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 3 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 10

  1. Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer. First author DOI 10.1016/j.omto.2020.08.002↗
  2. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Last author DOI 10.1016/j.phymed.2018.03.055↗
  3. Exploring brusatol as a new anti-pancreatic cancer adjuvant: biological evaluation and mechanistic studies. Co-author DOI 10.18632/oncotarget.17761↗
  4. Brucein D, a Naturally Occurring Tetracyclic Triterpene Quassinoid, Induces Apoptosis in Pancreatic Cancer through ROS-Associated PI3K/Akt Signaling Pathway. Co-author DOI 10.3389/fphar.2017.00936↗
  5. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer. First author DOI 10.1016/j.biocel.2014.05.021↗
  6. Establishment of an orthotopic model of pancreatic cancer to evaluate the antitumor effects of irinotecan through the biomarker carbohydrate antigen 19-9 in mi… Last author DOI 10.1097/mpa.0000000000000183↗
  7. Eriocalyxin B-induced apoptosis in pancreatic adenocarcinoma cells through thiol-containing antioxidant systems and downstream signalling pathways. Last author DOI 10.2174/1566524014666140603102459↗
  8. Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Last author DOI 10.1016/j.taap.2012.04.021↗
  9. Seven quassinoids from Fructus Bruceae with cytotoxic effects on pancreatic adenocarcinoma cell lines. Co-author DOI 10.1002/ptr.3477↗
  10. Role of the RAS in pancreatic cancer. First author DOI 10.2174/156800911795538110↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bao Chen Yang · 1 shared paper, 2020 · strength 0.24
  2. Zheng Lu · 2 shared papers, 2017 · strength 0.15
  3. Zhengquan Lai · 2 shared papers, 2017 · strength 0.15
  4. Zhi‐Xiu Lin · 2 shared papers, 2017 · strength 0.15
  5. Leung V. Li · 2 shared papers, 2014–2018 · strength 0.12
  6. Li Lin · 1 shared paper, 2014 · strength 0.09
  7. S. T. Lau · 2 shared papers, 2011 · strength 0.09
  8. Zhao‐Shen Li · 1 shared paper, 2017 · strength 0.08
  9. Yan‐Fang Xian · 1 shared paper, 2017 · strength 0.07
  10. Lin Li · 1 shared paper, 2014 · strength 0.05
  11. Ming Zhao · 1 shared paper, 2011 · strength 0.03
  12. Zhiqiang Lin · 1 shared paper, 2011 · strength 0.03
  13. Lin Li · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.